-
BMS-777607: A Mechanistic Assay Guide
2026-09-13
BMS-777607 is a selective c-Met inhibitor for resolving MET-family signaling in cancer and stem-cell assays. This guide connects its biochemical profile with an optimized iPSC-derived platelet study while emphasizing controls, assay maturity, and interpretation limits.
-
Wallichinine Reverses ABCB1-Mediated MDR
2026-09-12
The 2016 study by Lv and colleagues identifies wallichinine as a natural-product inhibitor of ABCB1-mediated multidrug resistance, showing that it restores the activity of vincristine and doxorubicin in ABCB1-overexpressing cancer cells. Its combined cytotoxicity, drug-transport, ATPase, and modeling experiments provide a mechanistic framework for evaluating ABCB1 reversal agents while highlighting the limits of metabolic viability readouts alone.
-
Acetoacetic Acid Sodium Salt Workflows
2026-09-11
Build reproducible ketone-body experiments with a water-soluble sodium acetoacetate format, practical dosing guidance, and controls for diabetes and energy metabolism models. A deuterium-labeling study adds an analytical lesson: rigorous standardization and orthogonal verification can make metabolic measurements more defensible.
-
EZ Cap Cy5 Firefly Luciferase mRNA Workflow
2026-09-11
Use one transcript to separate cellular delivery from productive translation: Cy5 reveals where mRNA travels, while Firefly Luciferase reports functional protein expression. This workflow shows how to optimize transfection, compare lipid nanoparticles, and troubleshoot intracellular trafficking with quantitative fluorescence and bioluminescence readouts.
-
Cichoric Acid, HIF-1α, and Septic AKI
2026-09-10
The reference study identifies a metabolic–inflammatory mechanism linking M1 macrophage polarization, succinate dehydrogenase activity, HIF-1α-driven glycolysis, and NLRP3 activation in sepsis-induced acute kidney injury. Its integrated cell and mouse experiments show that cichoric acid protects renal tissue while providing a framework for evaluating immunometabolic interventions.
-
Bobcat339: TET Inhibition for DNA Methylation Studies
2026-09-10
Bobcat339 is a cytosine structure-based TET enzyme inhibitor for separating TET1/TET2-dependent DNA demethylation from UHRF1-driven methylation biology. This workflow connects biochemical inhibition with methylation, super-enhancer, transcriptional, autophagy, and osteogenic readouts while emphasizing dose validation and mechanism-specific controls.
-
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Assays
2026-09-09
Learn how EZ Cap™ Cy5 EGFP mRNA (5-moUTP), SKU R1011, separates mRNA uptake from functional translation in viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers controls, handling, interpretation, vendor selection, and translational relevance.
-
Matrine: Mechanisms, Evidence, and Protocols
2026-09-09
Matrine is a Sophora-derived quinolizidine alkaloid with preclinical anticancer and anti-inflammatory activity. Evidence supports apoptosis induction, ROS generation, and signaling changes, but thymoma mechanisms remain hypothesis-generating rather than clinically validated.
-
Bleomycin Sulfate: From Damage to Translation
2026-09-08
Bleomycin Sulfate is more than a cytotoxic reagent: it is a mechanistic bridge between DNA damage, cancer response, and pulmonary fibrosis research. This thought-leadership guide shows how translational teams can move beyond single-point viability assays toward time-resolved, interpretable models.
-
Phosphatase Inhibitor Cocktail 1 Workflow
2026-09-08
Protect labile phosphorylation signals from harvest through analysis with a practical 100X DMSO-based workflow. This guide connects phosphatase control to YAP/Hippo pathway research, phosphoproteomics, immunoprecipitation, and troubleshooting decisions that improve interpretability.
-
ARCA Cy5 EGFP mRNA (5-moUTP) Workflow
2026-09-07
Use one reporter to separate cellular uptake from productive protein expression in mammalian mRNA delivery experiments. Direct Cy5 tracking, EGFP translation, ARCA capping, and 5-methoxyuridine modification support practical screening of carriers, formulations, and intracellular trafficking.
-
Escitalopram Workflows for Translational Research
2026-09-07
Escitalopram supports precise 5-HTT inhibition studies, pathway profiling, and translational antidepressant research with a workflow designed around selectivity and assay reproducibility. Its value is especially clear when depression-related and anxiety-related readouts are separated rather than treated as interchangeable endpoints.
-
Copper-Catalyzed Thioazafluoranthene Synthesis
2026-09-05
The reference study reports a copper-catalyzed radical cascade that converts N-tosyl-8-ethynyl-1-naphthylamines into sulfur- and nitrogen-doped fluoranthene frameworks under air. Beyond establishing a practical route to 2H-benzo[e][1,2]thiazine 1,1-dioxides, the work identifies these products as fluorescent scaffolds with a notably large Stokes shift, supporting their further evaluation in molecular materials and sensing research.
-
Cepharanthine in Endometriosis: Evidence and Limits
2026-09-04
A 2026 study evaluated the biscoclaurine alkaloid Cepharanthine across endometriotic stromal cells, patient-derived endometrial organoids, and a murine peritoneal model. The concordant findings connect lesion-growth suppression with G0/G1 arrest, DNA damage, impaired repair, and mitochondria-linked apoptosis, while also defining the preclinical evidence gaps before clinical translation.
-
Sulfo-NHS-Biotin for Protein Labeling
2026-09-04
Sulfo-NHS-Biotin is a water-soluble, amine-reactive protein labeling reagent for covalent biotinylation of lysine side chains and N-terminal amines. Its membrane-impermeant behavior supports cell surface protein labeling, while its biotin handle supports affinity chromatography biotinylation and immunoprecipitation workflows.